Market Overview:
The global pigmentation disorder therapeutic market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of pigmentation disorders, rising awareness about available treatment options, and growing demand for minimally invasive treatments. The global pigmentation disorder therapeutic market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into pharmacological treatment and cosmetic treatment. Pharmacological treatments are further sub-segmented into topical drugs, hydroquinone, L-ascorbic acid etc., while cosmetic treatments are sub-segmented into chemical peel laser therapy skin grafting etc. On the basis of application, the market is segmented into dermatology clinics drugstores and cosmetic stores aesthetic clinics ecommerce others .Region wise ,the global pigmentation disorder therapeuticmarketis segmentedin North America Latin America Europe Asia Pacificand Middle East & Africa . Surgical procedures such as laser therapy or skin grafting are gaining popularity due to their minimally invasive nature.
Product Definition:
Pigmentation disorder therapy is the use of treatments to improve the appearance of skin with abnormal pigmentation. Treatment may include topical medications, laser therapy, or surgery. The importance of pigmentation disorder therapy is that it can improve the appearance and self-esteem of those affected by the condition.
Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.):
The global pharmacological treatment market for pigment disorders was valued at USD 1.8 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.):
Cosmetic treatment is a set of procedures that are used to improve the appearance and health of the skin. These treatments include chemical peels, laser therapy, skin grafting, etc.
Application Insights:
The others segment held the largest share of around 54.0% in 2017. The segment includes plastic surgery and dermatology clinics that practice non-invasive procedures for pigmentation disorders. These clinics provide a wide range of services including consultation, diagnosis, and treatment for these disorders using various methods such as chemical peels, laser therapy, skin grafts & patches, etc. Dermatology clinics are expected to witness lucrative growth over the forecast period owing to increasing awareness about these treatments coupled with rising disposable income levels in developing countries such as India and China.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of skin cancer and melanoma, growing consumer awareness about early diagnosis, rising adoption of cosmeceuticals, and availability of effective treatment methods. Moreover, presence of key players in this region with extensive research on pigmentation disorders is also one among the factors responsible for regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing disposable income coupled with growing medical tourism industry in emerging countries such as India & China & Malaysia & Singapore etc., which will lead towards an increase in demand for therapeutics used for pigment disorders like hydroxyapatite (HAP) and vitamin C (ascorbic acid). In addition, rise in e-commerce distribution channels will further boost revenue generation from this region.
Growth Factors:
- Increasing prevalence of pigmentation disorders: The global prevalence of pigmentary disorders is increasing due to various factors such as changing lifestyles, pollution, and increasing awareness about these conditions. This is expected to drive the demand for pigmentation disorder therapeutics in the coming years.
- Growing R&D investments in pigmentation disorder therapeutics: There is a growing focus on R&D for novel therapies for treating pigmentary disorders, owing to the unmet needs in this area. This is expected to result in the development of better and more efficacious treatments over time, which will boost the market growth.
- Launch of new products: Several players are actively engaged in developing novel therapies for treating pigmentary disorders, with several products being launched every year. This will provide patients with additional treatment options and help fuel market growth over time.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pigmentation Disorder Therapeutic Market Research Report
By Type
Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.), Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
By Application
Dermatology Clinics, Drugstores and Cosmetic Stores, Aesthetic Clinics, E-commerce, Others
By Companies
Bayer, Allergan, Episciences, La Roche-Posay, SkinCeuticals, Pierre Fabre, Alvogen, Obagi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Pigmentation Disorder Therapeutic Market Report Segments:
The global Pigmentation Disorder Therapeutic market is segmented on the basis of:
Types
Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.), Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dermatology Clinics, Drugstores and Cosmetic Stores, Aesthetic Clinics, E-commerce, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Allergan
- Episciences
- La Roche-Posay
- SkinCeuticals
- Pierre Fabre
- Alvogen
- Obagi
Highlights of The Pigmentation Disorder Therapeutic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
- Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
- By Application:
- Dermatology Clinics
- Drugstores and Cosmetic Stores
- Aesthetic Clinics
- E-commerce
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pigmentation Disorder Therapeutic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pigmentation disorder therapeutic is a term used to describe treatments for conditions that cause abnormal pigmentation. These treatments can help to improve the appearance of skin color and may also help to reduce the number of spots or blemishes on the skin.
Some of the key players operating in the pigmentation disorder therapeutic market are Bayer, Allergan, Episciences, La Roche-Posay, SkinCeuticals, Pierre Fabre, Alvogen, Obagi.
The pigmentation disorder therapeutic market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pigmentation Disorder Therapeutic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pigmentation Disorder Therapeutic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pigmentation Disorder Therapeutic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pigmentation Disorder Therapeutic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pigmentation Disorder Therapeutic Market Size & Forecast, 2018-2028
4.5.1 Pigmentation Disorder Therapeutic Market Size and Y-o-Y Growth
4.5.2 Pigmentation Disorder Therapeutic Market Absolute $ Opportunity
Chapter 5 Global Pigmentation Disorder Therapeutic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pigmentation Disorder Therapeutic Market Size Forecast by Type
5.2.1 Pharmacological Treatment (Topical Drugs
5.2.2 Hydroquinone
5.2.3 L-Ascorbic Acid
5.2.4 etc.)
5.2.5 Cosmetic Treatment (Chemical Peel
5.2.6 Laser Therapy
5.2.7 Skin Grafting
5.2.8 etc.)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pigmentation Disorder Therapeutic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pigmentation Disorder Therapeutic Market Size Forecast by Applications
6.2.1 Dermatology Clinics
6.2.2 Drugstores and Cosmetic Stores
6.2.3 Aesthetic Clinics
6.2.4 E-commerce
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pigmentation Disorder Therapeutic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pigmentation Disorder Therapeutic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pigmentation Disorder Therapeutic Analysis and Forecast
9.1 Introduction
9.2 North America Pigmentation Disorder Therapeutic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pigmentation Disorder Therapeutic Market Size Forecast by Type
9.6.1 Pharmacological Treatment (Topical Drugs
9.6.2 Hydroquinone
9.6.3 L-Ascorbic Acid
9.6.4 etc.)
9.6.5 Cosmetic Treatment (Chemical Peel
9.6.6 Laser Therapy
9.6.7 Skin Grafting
9.6.8 etc.)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pigmentation Disorder Therapeutic Market Size Forecast by Applications
9.10.1 Dermatology Clinics
9.10.2 Drugstores and Cosmetic Stores
9.10.3 Aesthetic Clinics
9.10.4 E-commerce
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pigmentation Disorder Therapeutic Analysis and Forecast
10.1 Introduction
10.2 Europe Pigmentation Disorder Therapeutic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pigmentation Disorder Therapeutic Market Size Forecast by Type
10.6.1 Pharmacological Treatment (Topical Drugs
10.6.2 Hydroquinone
10.6.3 L-Ascorbic Acid
10.6.4 etc.)
10.6.5 Cosmetic Treatment (Chemical Peel
10.6.6 Laser Therapy
10.6.7 Skin Grafting
10.6.8 etc.)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pigmentation Disorder Therapeutic Market Size Forecast by Applications
10.10.1 Dermatology Clinics
10.10.2 Drugstores and Cosmetic Stores
10.10.3 Aesthetic Clinics
10.10.4 E-commerce
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pigmentation Disorder Therapeutic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pigmentation Disorder Therapeutic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pigmentation Disorder Therapeutic Market Size Forecast by Type
11.6.1 Pharmacological Treatment (Topical Drugs
11.6.2 Hydroquinone
11.6.3 L-Ascorbic Acid
11.6.4 etc.)
11.6.5 Cosmetic Treatment (Chemical Peel
11.6.6 Laser Therapy
11.6.7 Skin Grafting
11.6.8 etc.)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pigmentation Disorder Therapeutic Market Size Forecast by Applications
11.10.1 Dermatology Clinics
11.10.2 Drugstores and Cosmetic Stores
11.10.3 Aesthetic Clinics
11.10.4 E-commerce
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pigmentation Disorder Therapeutic Analysis and Forecast
12.1 Introduction
12.2 Latin America Pigmentation Disorder Therapeutic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pigmentation Disorder Therapeutic Market Size Forecast by Type
12.6.1 Pharmacological Treatment (Topical Drugs
12.6.2 Hydroquinone
12.6.3 L-Ascorbic Acid
12.6.4 etc.)
12.6.5 Cosmetic Treatment (Chemical Peel
12.6.6 Laser Therapy
12.6.7 Skin Grafting
12.6.8 etc.)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pigmentation Disorder Therapeutic Market Size Forecast by Applications
12.10.1 Dermatology Clinics
12.10.2 Drugstores and Cosmetic Stores
12.10.3 Aesthetic Clinics
12.10.4 E-commerce
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pigmentation Disorder Therapeutic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pigmentation Disorder Therapeutic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pigmentation Disorder Therapeutic Market Size Forecast by Type
13.6.1 Pharmacological Treatment (Topical Drugs
13.6.2 Hydroquinone
13.6.3 L-Ascorbic Acid
13.6.4 etc.)
13.6.5 Cosmetic Treatment (Chemical Peel
13.6.6 Laser Therapy
13.6.7 Skin Grafting
13.6.8 etc.)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pigmentation Disorder Therapeutic Market Size Forecast by Applications
13.10.1 Dermatology Clinics
13.10.2 Drugstores and Cosmetic Stores
13.10.3 Aesthetic Clinics
13.10.4 E-commerce
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pigmentation Disorder Therapeutic Market: Competitive Dashboard
14.2 Global Pigmentation Disorder Therapeutic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Allergan
14.3.3 Episciences
14.3.4 La Roche-Posay
14.3.5 SkinCeuticals
14.3.6 Pierre Fabre
14.3.7 Alvogen
14.3.8 Obagi
